LRMR
Price
$2.77
Change
-$0.08 (-2.80%)
Updated
Oct 6, 11:07 AM (EDT)
Capitalization
329.31M
30 days until earnings call
Intraday BUY SELL Signals
OLMA
Price
$7.99
Change
-$0.26 (-3.15%)
Updated
Oct 6, 02:48 PM (EDT)
Capitalization
753.35M
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LRMR vs OLMA

LRMR vs OLMA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LRMR vs. OLMA commentary
Oct 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRMR is a Hold and OLMA is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
LRMR vs OLMA: Fundamental Ratings
LRMR
OLMA
OUTLOOK RATING
1..100
7567
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
8388
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
4350

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OLMA's Valuation (19) in the null industry is in the same range as LRMR (25). This means that OLMA’s stock grew similarly to LRMR’s over the last 12 months.

OLMA's Profit vs Risk Rating (100) in the null industry is in the same range as LRMR (100). This means that OLMA’s stock grew similarly to LRMR’s over the last 12 months.

OLMA's SMR Rating (98) in the null industry is in the same range as LRMR (100). This means that OLMA’s stock grew similarly to LRMR’s over the last 12 months.

LRMR's Price Growth Rating (83) in the null industry is in the same range as OLMA (88). This means that LRMR’s stock grew similarly to OLMA’s over the last 12 months.

LRMR's P/E Growth Rating (100) in the null industry is in the same range as OLMA (100). This means that LRMR’s stock grew similarly to OLMA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LRMROLMA
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 21 days ago
84%
Bullish Trend 29 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
COMPARISON
Comparison
Oct 06, 2026
Stock price -- (LRMR: $2.86 vs. OLMA: $8.25)
Brand notoriety: LRMR and OLMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LRMR: 75% vs. OLMA: 84%
Market capitalization -- LRMR: $329.31M vs. OLMA: $753.35M
LRMR [@Biotechnology] is valued at $329.31M. OLMA’s [@Biotechnology] market capitalization is $753.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LRMR’s FA Score shows that 1 FA rating(s) are green while OLMA’s FA Score has 1 green FA rating(s).

  • LRMR’s FA Score: 1 green, 4 red.
  • OLMA’s FA Score: 1 green, 4 red.
According to our system of comparison, both LRMR and OLMA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LRMR’s TA Score shows that 4 TA indicator(s) are bullish while OLMA’s TA Score has 4 bullish TA indicator(s).

  • LRMR’s TA Score: 4 bullish, 6 bearish.
  • OLMA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, OLMA is a better buy in the short-term than LRMR.

Price Growth

LRMR (@Biotechnology) experienced а -9.78% price change this week, while OLMA (@Biotechnology) price change was -4.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.87%. For the same industry, the average monthly price growth was -14.47%, and the average quarterly price growth was -3.41%.

Reported Earning Dates

LRMR is expected to report earnings on Nov 05, 2026.

OLMA is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-2.87% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
LRMR
Daily Signal:
Gain/Loss:
OLMA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DVGR25.930.17
+0.67%
DAC 3D Dividend Growth ETF (DVGR)
DSTX33.910.16
+0.48%
Distillate International Fundamental Stability & Value ETF (DSTX)
SOXL164.270.56
+0.34%
Direxion Daily Semiconductor Bull 3X ETF (SOXL)
SDVD22.000.01
+0.05%
FT Vest SMID Rising Dividend Achievers Target Income ETF (SDVD)
TZA44.82-0.95
-2.08%
Direxion Daily Small Cap Bear 3X ETF (TZA)

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with AMLX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
-3.38%
AMLX - LRMR
45%
Loosely correlated
-0.04%
MLTX - LRMR
42%
Loosely correlated
-0.26%
CLDX - LRMR
40%
Loosely correlated
+2.97%
REPL - LRMR
40%
Loosely correlated
+0.61%
VIR - LRMR
39%
Loosely correlated
+5.46%
More